BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11642612)

  • 1. Overexpressed cell surface interleukin-4 receptor molecules can be successfully targeted for antitumor cytotoxin therapy.
    Kawakami K; Kawakami M; Puri RK
    Crit Rev Immunol; 2001; 21(1-3):299-310. PubMed ID: 11642612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ expression of interleukin-4 (IL-4) receptors in human brain tumors and cytotoxicity of a recombinant IL-4 cytotoxin in primary glioblastoma cell cultures.
    Joshi BH; Leland P; Asher A; Prayson RA; Varricchio F; Puri RK
    Cancer Res; 2001 Nov; 61(22):8058-61. PubMed ID: 11719427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 4 receptor on human lung cancer: a molecular target for cytotoxin therapy.
    Kawakami M; Kawakami K; Stepensky VA; Maki RA; Robin H; Muller W; Husain SR; Puri RK
    Clin Cancer Res; 2002 Nov; 8(11):3503-11. PubMed ID: 12429641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 4 receptor-directed cytotoxin therapy for human head and neck squamous cell carcinoma in animal models.
    Strome SE; Kawakami K; Alejandro D; Voss S; Kasperbauer JL; Salomao D; Chen L; Maki RA; Puri RK
    Clin Cancer Res; 2002 Jan; 8(1):281-6. PubMed ID: 11801570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-4-Pseudomonas exotoxin chimeric fusion protein for malignant glioma therapy.
    Kawakami M; Kawakami K; Puri RK
    J Neurooncol; 2003 Oct; 65(1):15-25. PubMed ID: 14649882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and targeting of interleukin-4 receptor for primary and advanced ovarian cancer therapy.
    Kioi M; Takahashi S; Kawakami M; Kawakami K; Kreitman RJ; Puri RK
    Cancer Res; 2005 Sep; 65(18):8388-96. PubMed ID: 16166317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of antitumor activity of an interleukin-13 (IL-13) receptor-targeted cytotoxin composed of IL-13 antagonist and Pseudomonas exotoxin.
    Kioi M; Kawakami K; Puri RK
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6231-8. PubMed ID: 15448012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of interleukin-13 in cancer, pulmonary fibrosis, and other T(H)2-type diseases.
    Joshi BH; Hogaboam C; Dover P; Husain SR; Puri RK
    Vitam Horm; 2006; 74():479-504. PubMed ID: 17027527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure, function, and targeting of interleukin 4 receptors on human head and neck cancer cells.
    Kawakami K; Leland P; Puri RK
    Cancer Res; 2000 Jun; 60(11):2981-7. PubMed ID: 10850446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Internalization property of interleukin-4 receptor alpha chain increases cytotoxic effect of interleukin-4 receptor-targeted cytotoxin in cancer cells.
    Kawakami K; Kawakami M; Leland P; Puri RK
    Clin Cancer Res; 2002 Jan; 8(1):258-66. PubMed ID: 11801567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4.
    Obiri NI; Hillman GG; Haas GP; Sud S; Puri RK
    J Clin Invest; 1993 Jan; 91(1):88-93. PubMed ID: 8423237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting interleukin-4 receptors for effective pancreatic cancer therapy.
    Kawakami K; Kawakami M; Husain SR; Puri RK
    Cancer Res; 2002 Jul; 62(13):3575-80. PubMed ID: 12097255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-4 receptor-directed cytotoxin for therapy of AIDS-associated KS tumors.
    Puri RK
    Drug News Perspect; 2000 Sep; 13(7):395-402. PubMed ID: 12937611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of high-affinity interleukin 4 receptors on murine sarcoma cells and receptor-mediated cytotoxicity of tumor cells to chimeric protein between interleukin 4 and Pseudomonas exotoxin.
    Puri RK; Ogata M; Leland P; Feldman GM; FitzGerald D; Pastan I
    Cancer Res; 1991 Jun; 51(11):3011-7. PubMed ID: 2032239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumoral administration of recombinant circularly permuted interleukin-4-Pseudomonas exotoxin in patients with high-grade glioma.
    Rand RW; Kreitman RJ; Patronas N; Varricchio F; Pastan I; Puri RK
    Clin Cancer Res; 2000 Jun; 6(6):2157-65. PubMed ID: 10873064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of interleukin (IL)-4 cytotoxin on breast tumor growth after in vivo gene transfer of IL-4 receptor alpha chain.
    Kawakami K; Kawakami M; Husain SR; Puri RK
    Clin Cancer Res; 2003 May; 9(5):1826-36. PubMed ID: 12738741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-4 receptors on human medulloblastoma tumours serve as a sensitive target for a circular permuted IL-4-Pseudomonas exotoxin fusion protein.
    Joshi BH; Leland P; Silber J; Kreitman RJ; Pastan I; Berger M; Puri RK
    Br J Cancer; 2002 Jan; 86(2):285-91. PubMed ID: 11870521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined effects of radiation and interleukin-13 receptor-targeted cytotoxin on glioblastoma cell lines.
    Kawakami K; Kawakami M; Liu Q; Puri RK
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):230-7. PubMed ID: 16111594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
    O'Malley BW; Li D; McQuone SJ; Ralston R
    Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent antitumor activity of IL-13 cytotoxin in human pancreatic tumors engineered to express IL-13 receptor alpha2 chain in vivo.
    Kawakami K; Kawakami M; Husain SR; Puri RK
    Gene Ther; 2003 Jul; 10(13):1116-28. PubMed ID: 12808442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.